Further investigations showed that by binding to HPV16 E6, affibody ZHPV16E61235 blocked E6-mediated p53 degradation and specifically inhibited the cell viability and proliferation of HPV16-positive cancer cells. This evidence concerns the gene TP53 and cancer.